XenoTherapeutics Corp

Enfield, NH · Founded 2019 · CIK 0001774010 · Biotech · Private

xenotransplantation therapies and organ transplant systems using genetically modified animal organs

xenotx.org →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.3M
2 Form D · Apr 2021
66 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,000,000
Private capital raisedForm D · SEC$1,325,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1604CeleCor Therapeutics, Inc.—$3.7M
1605THERALINK TECHNOLOGIES, INC.—$2.6M
1606Reglagene, LLC—$1.9M
1607XenoTherapeutics Corp—$1.3M
1608RIBO-THERAPEUTICS LLC——
1609Yuva Biosciences, Inc.—$1.1M
1610CEL-SCI CORPORATION—$1.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Jon AdkinsDirector · Executive Officer
  • Paul HolzerDirector · Executive Officer
  • Krysta MoultonDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.